LAS VEGAS, July 8, 2020 /PRNewswire/ -- JanOne Inc.
(NASDAQ:JAN), a company focused on finding treatments for
conditions that cause severe pain and bringing to market drugs and
therapies with non-addictive pain-relieving properties, continues
to broaden the medical and clinical competency of its scientific
advisory board. We are proud to announce the addition of two
renowned researchers from the University of
Alabama at Birmingham, Rakesh
Patel, PhD, and Timothy Ness,
MD, PhD. Dr. Patel lends significant scientific knowledge in
molecular and cellular pathology and Dr. Ness brings an extensive
pain research portfolio with focus on mechanisms of pain for
various indications.
"It is with great admiration that I welcome Drs. Patel and Ness
to our scientific advisory board, especially as we continue our
journey to build JanOne into a world-class biopharma organization,"
said Tony Isaac, JanOne's chief
executive officer.
Dr. Patel is internationally recognized for his research to
regulate acute and chronic inflammation and associated therapeutic
development. Most noted is his research to understand the molecular
basis of nitric oxide, and nitrite interactions with organs and red
blood cells. Patel is also known for his work to understand the
impacts on the biological process associated with blood flow
regulation and pulmonary function. He has authored and contributed
to over 200 articles, manuscripts and book chapters and has been a
featured speaker at research symposia around the world.
"I am excited to join the JanOne Scientific advisory board and
to work with such a talented team of physicians and scientific
leaders. I believe my research experience with nitrite biology and
therapeutics will play a role in advancing the company's peripheral
artery disease (PAD) treatment currently in clinic as well as
future pain and disease indications," said Dr. Patel.
Dr. Patel received his Ph.D. from the University of Essex, UK, in 1996 and is currently Vice Chair
for Research, Department of Pathology, and Director of the Center
for Free Radical Biology at the University of
Alabama at Birmingham (UAB).
Timothy Ness, MD, PhD, is
Professor Emeritus and former Pain Treatment Division Chief,
Director of Pain Research and Vice Chair for Clinical Research in
the Department of Anesthesiology and Perioperative Medicine at the
University of Alabama at Birmingham
(UAB). His prolific research portfolio focuses on
multiple aspects and mechanisms of pain, most notably related to
neuropathic and visceral pains, neuromodulation and spinal cord
injury.
Dr. Ness has published over 200 manuscripts and numerous book
chapters and has been involved in multiple clinical trials studying
new pain medications. He has served as a clinical research
expert on pain for the National Institutes of Health (NIH), Food
and Drug Administration (FDA) advisory panels, the Veterans
Administration (VA), and various international research institutes.
He has served on the American Pain Society and the American Society
of Regional Anesthesia and Pain Medicine Board of Directors. He is
currently funded by the NIH.
"JanOne presents a unique opportunity for me to contribute my
medical and research expertise to treatments for diseases that
cause severe pain and to find non-addictive pain solutions," said
Dr. Ness. "It is with great appreciation that I join their
scientific advisory board."
About JanOne
JanOne is a unique NASDAQ-listed company that is focused on
bringing medications to market to treat diseases that cause severe
pain in an effort to reduce the need for prescriptions opioids
often used to treat disease associated pain. The company is also
exploring solutions for non-addictive pain medications. The lead
candidate is for treating peripheral artery disease (PAD), a
condition that affects over 8.5 million Americans, with plans
currently underway for phase 2b
trials. JanOne is currently dedicated to funding resources toward
innovation, technology, and education for PAD and neuropathic pain.
The company continues to operate its legacy businesses, ARCA
Recycling and GeoTraq, under their current brand names, but has
recently announced both are undergoing a review to determine
appropriate strategic alternatives in an effort to focus on it
biopharma interests. ARCA Recycling provides turnkey recycling and
replacement services for utilities and other sponsors of energy
efficiency programs. GeoTraq engages in the development, design
and, ultimately, the company expects, sale of Mobile IoT modules.
Please visit www.janone.com for additional information.
Media contact:
Mark Rosenberg
mark@trueparallel.com
919-412-7378
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dr-rakesh-patel-internationally-recognized-scientist-in-nitric-oxide-and-redox-biology-and-dr-timothy-ness-a-pain-mechanisms-and-medication-expert-join-janones-scientific-advisory-board-301090042.html
SOURCE JanOne